Sapyen Announces Integration of Male Fertility Testing Across Ivy Fertility Network

Sapyen has introduced its advanced home-based male fertility test kit into the Ivy Fertility network. This collaboration marks a major step toward making male reproductive health testing more accessible and standardized. Men can now complete lab-quality semen analysis from home, with results processed in Ivy’s partner laboratories under expert clinical supervision.

Addressing Male Fertility Imbalance

The initiative corrects a long-standing gap in fertility diagnostics. Although medical guidelines recommend testing both partners at the start of treatment, male testing often occurs late. This delay can lead to unnecessary procedures, wasted time, and additional emotional and financial strain for families.

With the Sapyen test kit, men can collect samples conveniently at home. Partner laboratories then perform validated analyses, including semen parameters and DNA fragmentation tests.

Ashwin Ramachandran, CEO of Sapyen, emphasized the importance of shared responsibility in fertility testing. “Infertility has traditionally placed most of the testing and treatment burden on women,” he said. “By integrating accurate, lab-grade male testing into fertility networks, we ensure both partners are evaluated early. This approach improves clinical efficiency, reduces stress, and helps families avoid unnecessary treatments.”

Comprehensive and Inclusive Fertility Care

Lisa Van Dolah, CEO of Ivy Fertility, described the partnership as a major shift toward inclusive reproductive care. “For decades, fertility treatment focused mainly on women,” she said. “Now, by supporting both partners together, we can prevent unnecessary procedures, deliver clearer answers sooner, and create a compassionate path to parenthood. Inclusive care leads to better outcomes for families.”

Fertility treatments in the U.S. continue to grow rapidly, with assisted reproductive technology (ART) cycles accounting for an increasing number of births. As insurance coverage expands, efficient and evidence-based testing becomes essential. The integration of Sapyen’s technology supports these improvements by making early testing more consistent and patient-focused.

Streamlined Testing Through Collaboration

By merging Sapyen’s at-home collection system with Ivy Fertility’s established clinical network, the partnership creates a smooth, inclusive, and patient-centered fertility assessment process. It simplifies diagnostics, reduces clinic visits, and provides faster, data-backed results for couples beginning their fertility journey.

About Sapyen

Sapyen develops reliable, home-based male fertility diagnostics to make sperm testing more accurate and convenient. Its proprietary transport medium keeps samples viable for extended periods, ensuring lab-grade analysis through certified partner labs. The platform delivers detailed semen evaluations and advanced assays, offering both couples and clinicians clear insights into reproductive health.

About Ivy Fertility

Ivy Fertility is a national network of fertility centers specializing in reproductive medicine, in-vitro fertilization (IVF), and fertility research. The organization is dedicated to improving patient care through innovation, collaboration, and scientific excellence. Its partnership with Sapyen reflects its commitment to advancing comprehensive fertility solutions for all families.

Company Details

Organization: Sapyen

Contact Person: Ash

Website: https://www.sapyen.co/

Email: ash@sapyen.co

City: San Francisco

State: CA

Country: United States

Release Id: 24102536001